Di-Methyl-Histone H3 (Lys14) Antibody

Basic Research Questions

• What is Di-Methyl-Histone H3 (Lys14) and why is it significant in epigenetic research?

  Di-Methyl-Histone H3 (Lys14) refers to histone H3 protein dimethylated at the lysine 14 position. Histone H3 is one of the core components of nucleosomes, which are the fundamental subunits of chromatin consisting of 146 base pairs of DNA wrapped around an octamer of core histone proteins (two each of H2A, H2B, H3, and H4) .

  The dimethylation of H3 at Lys14 represents an important epigenetic modification that contributes to chromatin regulation. Unlike better-studied methylation sites such as H3K4, H3K9, and H3K27, methylation at the K14 position has distinctive roles in gene regulation. Research indicates that H3K14 methylation states work in concert with other histone modifications to regulate chromatin structure and function .

  Methodologically, studying this modification requires highly specific antibodies that can distinguish between unmethylated, monomethylated, dimethylated, and trimethylated states at this particular lysine residue.

• How do researchers distinguish Di-Methyl-Histone H3 (Lys14) Antibodies from antibodies recognizing other methylation states?

  Distinguishing between antibodies that recognize different methylation states requires rigorous validation techniques:

  • Peptide Array Assays: These assess antibody cross-reactivity against known modifications across all histone proteins in a single experiment. This method has the added benefit of testing how neighboring modifications affect the antibody's ability to detect a specific modification site .

  • Western Blot Validation: For H3K14me2 antibodies, validation involves comparing reactivity against recombinant histone H3 (control) and acid extracts of cell lines. High-quality antibodies like RM165 show specific bands at the expected molecular weight (17 kDa) in cell extracts without cross-reactivity to other methylation states .

  • Specificity Testing: A properly validated antibody should demonstrate no cross-reactivity with non-modified Lys14 (H3K14), monomethylated Lys14 (K14me1), trimethylated Lys14 (K14me3), or other methylations in histone H3 .

  • Synthetic Peptide Analysis: Using synthetic peptides with defined modifications to compare binding affinities and confirm specificity for H3K14me2 versus other modifications .

• What are the standard applications for Di-Methyl-Histone H3 (Lys14) Antibody in epigenetic research?

  Di-Methyl-Histone H3 (Lys14) Antibodies are employed in multiple applications:

  Application	Typical Dilution	Purpose in Research
  Western Blotting (WB)	1:500-1:1,000	Detecting H3K14me2 in protein extracts
  Immunocytochemistry/Immunofluorescence (ICC/IF)	1:50-1:200	Visualizing nuclear distribution of H3K14me2
  Immunoprecipitation (IP)	1:50-1:200	Isolating H3K14me2-containing complexes
  Chromatin Immunoprecipitation (ChIP)	1:20-1:100	Identifying genomic regions enriched for H3K14me2
  ChIP-sequencing (ChIP-seq)	1:20-1:100	Genome-wide mapping of H3K14me2 distribution
  ELISA	0.2-1 μg/mL	Quantitative detection of H3K14me2
  Multiplex assays	0.1-0.5 μg/mL	Simultaneous detection with other modifications

  Each application requires specific optimization for antibody concentration, buffer conditions, and detection methods to achieve reliable results .

Intermediate Research Questions

• How does H3K14 dimethylation functionally differ from acetylation at the same position?

  H3K14 can undergo multiple modifications including acetylation and different degrees of methylation, each with distinct functional outcomes:

  • Acetylation vs. Dimethylation: H3K14 acetylation (H3K14ac) is generally associated with active transcription, while the dimethylation state (H3K14me2) has more complex and context-dependent functions .

  • Enzymatic Interactions: H3K14ac strongly inhibits LSD1 demethylase activity toward H3K4me2, representing a key regulatory mechanism. The Km and kcat of LHC (core CoREST complex) demethylase action on H3K4me2K14ac substrate are dramatically decreased (~20-fold) relative to non-acetylated substrates .

  • Modification Crosstalk: Research shows that H3K14ac confers a composite resistance in chromatin to the LHC enzymatic complex, which contains histone deacetylase HDAC1 and histone demethylase LSD1. This suggests that H3K14ac serves as a protective mark against gene silencing mechanisms .

  • Structural Impact: The dimethylation of H3K14 alters the physical and chemical properties of the histone tail differently than acetylation, affecting interactions with reader proteins that recognize specific histone modifications .

  Methodologically, researchers studying the functional differences between these modifications often employ semisynthetic nucleosome substrates with site-specific modifications to directly compare their effects on enzyme binding and activity .

• What validation methods should be used to confirm Di-Methyl-Histone H3 (Lys14) Antibody specificity?

  Comprehensive validation of Di-Methyl-Histone H3 (Lys14) Antibody specificity requires multiple approaches:

  1. Peptide Arrays: Using arrays that contain various histone modifications to determine if the antibody binds only to the intended target (H3K14me2) and not to other modifications or unmodified regions .

  2. Competitive Binding Assays: Testing antibody binding in the presence of competing peptides with different modifications to establish specificity factors (ratio of binding to target vs. non-target sites) .

  3. Dot Blot Analysis: Applying synthetic peptides with defined modifications to membranes to visualize binding patterns.

  4. Western Blot Comparison: Testing against recombinant histones with defined modifications and cellular extracts, looking for a single band at the expected 15-17 kDa size .

  5. ChIP-qPCR Controls: Performing ChIP at genomic regions known to be enriched or depleted for H3K14me2 to confirm expected patterns.

  6. Cross-Reactivity Testing: Specifically testing against:

     • Other H3K14 methylation states (H3K14me1, H3K14me3)

     • Similar modifications at different residues (H3K9me2, H3K4me2)

     • Other types of modifications at K14 (H3K14ac)

  7. Knockout/Knockdown Validation: Using cells with knockout/knockdown of enzymes responsible for H3K14 methylation to confirm reduced antibody signal.

  A specificity factor greater than two-fold difference between binding at the target site versus at the best non-target site is generally considered indicative of a specific antibody .

• How do neighboring histone modifications affect the detection of Di-Methyl-Histone H3 (Lys14)?

  Neighboring modifications can significantly impact the detection of H3K14me2 by antibodies:

  • Adjacent Modifications: Modifications at nearby residues (K9, K18, etc.) can sterically hinder antibody access to H3K14me2 or alter the conformation of the histone tail, affecting epitope recognition .

  • Combined Modifications: The presence of multiple modifications on the same histone tail can create combinatorial patterns that affect antibody binding. For example, phosphorylation at serine 10 (S10ph) may influence detection of K14 modifications .

  • Peptide Array Evidence: Peptide array assays specifically designed to test the effects of neighboring modifications show that antibody specificity can be significantly compromised when adjacent residues are modified .

  To address these challenges:

  1. Use antibodies validated against diverse modification patterns

  2. Perform control experiments with synthetic peptides bearing different combinations of modifications

  3. Consider alternative approaches like mass spectrometry for complex modification patterns

  4. When possible, verify findings using antibodies from different sources or with different epitope recognition properties

Advanced Research Questions

• How does Di-Methyl-Histone H3 (Lys14) modification interact with the CoREST complex to regulate gene expression?

  The interaction between H3K14 modifications and the CoREST complex reveals sophisticated epigenetic regulatory mechanisms:

  • CoREST Complex Structure: The core CoREST complex (LHC) contains histone deacetylase HDAC1 and histone demethylase LSD1 held together by the scaffold protein CoREST .

  • Modification-Dependent Inhibition: While H3K14 acetylation strongly inhibits LSD1 demethylase activity toward H3K4me2, the effects of H3K14 dimethylation appear to be distinct. The dimethylation state at K14 creates a different interaction profile with the LHC complex .

  • Enzymatic Kinetics: Detailed kinetic analysis shows that H3K14ac dramatically decreases (~20-fold) both Km and kcat of LHC demethylase action on H3K4me2 substrates compared to non-acetylated substrates. This inhibition appears to be associated with a stabilized enzyme-substrate ground state complex for H3K4me2K14ac .

  • Nucleosomal Context Effects: The inhibitory effects of H3K14 modifications are more pronounced in nucleosomal contexts than with isolated histone tails, suggesting that chromatin structure plays a crucial role in these regulatory interactions .

  Methodologically, these interactions have been studied using:

  1. Purified enzyme complexes with modified peptide substrates

  2. Reconstituted semisynthetic mononucleosome substrates

  3. Kinetic enzyme assays measuring demethylase and deacetylase activities

  4. Competitive inhibition studies with hydroxamic acid modifications

  The research suggests that H3K14 modifications, including dimethylation, play central roles in creating composite patterns of chromatin that are either susceptible or resistant to gene silencing by corepressor complexes .

• What are the optimized protocols for ChIP-seq using Di-Methyl-Histone H3 (Lys14) Antibody in various cell types?

  Optimized ChIP-seq protocols for Di-Methyl-Histone H3 (Lys14) Antibody must address several technical considerations:

  Protocol Stage	Standard Approach	Optimization for H3K14me2
  Crosslinking	1% formaldehyde, 10 min	Dual crosslinking with DSG (2 mM, 45 min) followed by formaldehyde (1%, 10 min) may improve signal
  Chromatin Preparation	Sonication to 200-500 bp	Careful titration of sonication conditions to avoid epitope damage
  Antibody Amount	1-5 μg standard	Optimal range: 1-5 μg for 25 μg chromatin (adjust ratio based on cell type)
  Antibody Dilution	Varies by supplier	1:20-1:100 for ChIP applications
  Incubation Conditions	Overnight at 4°C	4-6 hours at 4°C may be sufficient and reduce background
  Washing Stringency	Standard ChIP washes	Additional high-salt washes may improve specificity
  Controls	IgG, input	Include H3 occupancy control and specificity controls with competing peptides

  Cell-Type Specific Considerations:

  • Adherent cells (e.g., HeLa): Standard protocol works well with 2-5×10^6 cells

  • Primary cells: May require gentler lysis conditions and optimization of antibody:chromatin ratios

  • Tissue samples: Additional homogenization steps and increased antibody amounts may be necessary

  • Low cell numbers: Consider using modified protocols designed for low input material

  For ChIP-seq library preparation, it's crucial to assess library quality before sequencing, as H3K14me2 may have a more focused distribution pattern than other histone marks like H3K4me3 or H3K27me3 .

• How can contradictory ChIP-seq data for Di-Methyl-Histone H3 (Lys14) be resolved through improved experimental design?

  Contradictory ChIP-seq data for H3K14me2 can arise from several sources and requires systematic troubleshooting:

  Sources of Contradiction:

  1. Antibody Specificity: Different antibodies may have varying degrees of specificity or recognize different epitopes, leading to different genomic profiles .

  2. Cross-Reactivity: Some antibodies may cross-react with similar modifications (H3K14me1, H3K14me3) or the same modification at different residues (e.g., H3K9me2) .

  3. Technical Variations: Differences in chromatin preparation, IP efficiency, library preparation, and sequencing depth.

  4. Biological Variability: Cell type-specific or condition-specific differences in H3K14me2 distribution.

  Resolution Strategies:

  1. Antibody Validation Suite:

     • Perform peptide competition assays

     • Use multiple antibodies from different sources/clones

     • Validate with peptide arrays to confirm specificity

  2. Spike-in Controls:

     • Use exogenous chromatin (e.g., Drosophila) as a normalization control

     • Include recombinant nucleosomes with defined modifications

  3. Orthogonal Validation:

     • Combine ChIP-seq with orthogonal methods like CUT&RUN or CUT&Tag

     • Validate key regions by ChIP-qPCR

     • Consider mass spectrometry validation of modifications

  4. Bioinformatic Solutions:

     • Apply more stringent peak calling criteria

     • Analyze co-occurrence with other modifications

     • Compare patterns across multiple datasets

     • Use differential binding analysis between conditions rather than absolute peak calls

  5. Biological Validation:

     • Perturb enzymes responsible for H3K14 methylation

     • Correlate with gene expression data

     • Use genetic approaches to alter H3K14 methylation state

  By implementing these strategies, researchers can better distinguish technical artifacts from true biological signals in H3K14me2 ChIP-seq data .

• What is the relationship between Di-Methyl-Histone H3 (Lys14) and other histone modifications in the context of the histone code?

  The relationship between H3K14me2 and other histone modifications reveals complex patterns of the histone code:

  • Inhibitory Relationships: H3K14 acetylation strongly inhibits LSD1 demethylase activity toward H3K4me2, creating a protective effect against demethylation. The presence of H3K14me2 likely establishes different interaction dynamics with chromatin-modifying complexes .

  • Synergistic/Antagonistic Patterns: Research indicates specific relationships between H3K14me2 and other modifications:

    • Synergistic with: H3K4me3 (activation), H3K36me3 (transcriptional elongation)

    • Antagonistic with: H3K9me3 (heterochromatin), H3K27me3 (Polycomb repression)

  • Nucleosomal Context Effects: H3K14 modifications show different functional effects in the context of nucleosomes compared to isolated histone tails, suggesting that chromatin structure influences how these modifications interact .

  • Enzymatic Dependencies: The existence of specific methyltransferases and demethylases targeting H3K14 indicates regulated pathways for establishing and removing this modification.

  • Sequential Modification Patterns: Evidence suggests that certain modifications must precede or follow others, creating a temporal dimension to the histone code. For example, the stability of H3K4me2 appears to be influenced by the presence of H3K14 modifications .

  Methodologically, these relationships are studied using:

  1. Sequential ChIP (re-ChIP) to detect co-occurrence on the same nucleosomes

  2. Mass spectrometry to identify modification combinations on the same histone tails

  3. Enzyme assays with modified substrates to test how one modification affects the addition/removal of another

  4. Genetic studies altering specific enzymes to observe changes in modification patterns

  Understanding these relationships is crucial for deciphering how H3K14me2 contributes to epigenetic regulation and gene expression patterns .

• How do Di-Methyl-Histone H3 (Lys14) patterns change during cellular differentiation and what are the technical challenges in measuring these changes?

  Tracking H3K14me2 changes during cellular differentiation presents specific challenges and requires specialized approaches:

  Biological Patterns:

  • During differentiation, H3K14me2 patterns undergo redistribution at key regulatory regions

  • In stem cells, H3K14me2 may co-occur with bivalent domains (H3K4me3/H3K27me3)

  • Lineage commitment often involves changes in H3K14me2 at developmental gene loci

  • Cell type-specific enhancers show distinctive H3K14me2 patterns during differentiation

  Technical Challenges:

  1. Sample Heterogeneity: Differentiating cell populations are often heterogeneous, diluting modification signals

  2. Limited Material: Rare cell populations or intermediate states may provide insufficient material for standard ChIP-seq

  3. Dynamic Changes: Rapid modification turnover during differentiation requires careful timing of experiments

  4. Antibody Specificity: Potential cross-reactivity with other modifications that change during differentiation

  5. Signal Normalization: Global changes in histone modification levels complicate normalization strategies

  Methodological Solutions:

  1. Single-Cell Approaches: Adapt CUT&Tag or similar methods for single-cell resolution

  2. Low-Input Protocols: Use specialized ChIP protocols designed for limited cell numbers

  3. Spike-in Controls: Include exogenous chromatin as normalization standards

  4. Time-Course Designs: Capture multiple timepoints throughout differentiation

  5. Integration with Other Data Types:

     • RNA-seq to correlate with gene expression changes

     • ATAC-seq to assess chromatin accessibility changes

     • Single-cell multi-omics for integrated analysis

  6. Antibody Validation: Perform specificity testing in the specific cellular contexts being studied

  7. Mass Spectrometry: Use targeted MS approaches to quantify H3K14me2 levels during differentiation

  By addressing these challenges, researchers can more accurately characterize the dynamic changes in H3K14me2 during cellular differentiation and their functional significance in cell fate decisions .